Saira S Siddiqui1, Richard F Armenta2, Jennifer L Evans3, Michelle Yu3, Jazmine Cuevas-Mota2, Kimberly Page3, Peter Davidson2, Richard S Garfein4. 1. Graduate School of Public Health, San Diego State University, San Diego, CA, USA. 2. Division of Global Public Health, School of Medicine, University of California San Diego, San Diego, CA, USA. 3. Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA. 4. Division of Global Public Health, School of Medicine, University of California San Diego, San Diego, CA, USA. Electronic address: rgarfein@ucsd.edu.
Abstract
BACKGROUND: Sharing blood-contaminated syringes is the main risk factor for acquiring and transmitting blood-borne infections among persons who inject drugs (PWID). To reduce this risk, in 2005, California enacted legislation allowing local health jurisdictions to legalize non-prescription syringe sales after approving a disease prevention demonstration project (DPDP). With San Francisco approving a DPDP immediately and San Diego never approving one, we compared PWID across cities for their use of pharmacies PWID to obtain syringes. METHODS: PWID age 18-30 years old were recruited into separate studies in San Francisco (n=243) and San Diego (n=338) between 2008 and 2011. We used multivariable logistic regression to compare the proportions of PWID who obtained syringes from pharmacies by city while controlling for sociodemographics, injection practices and other risk behaviors. RESULTS: Overall, most PWID were White (71%), male (63%), and between the ages of 18-25 years (55%). Compared to San Francisco, a smaller proportion of PWID in San Diego had bought syringes from pharmacies in the prior three months (16.9% vs. 49.8%; p<0.001), which remained statistically significant after adjusting for sociodemographic and behavioral factors (adjusted odds ratio=4.45, 95% confidence interval: 2.98, 6.65). CONCLUSIONS: Use of pharmacies to obtain syringes was greater where it was legal to do so. Public health policy can influence HIV and hepatitis C associated risk among PWID; however, implementation of these policies is crucial for the benefits to be realized.
BACKGROUND: Sharing blood-contaminated syringes is the main risk factor for acquiring and transmitting blood-borne infections among persons who inject drugs (PWID). To reduce this risk, in 2005, California enacted legislation allowing local health jurisdictions to legalize non-prescription syringe sales after approving a disease prevention demonstration project (DPDP). With San Francisco approving a DPDP immediately and San Diego never approving one, we compared PWID across cities for their use of pharmacies PWID to obtain syringes. METHODS: PWID age 18-30 years old were recruited into separate studies in San Francisco (n=243) and San Diego (n=338) between 2008 and 2011. We used multivariable logistic regression to compare the proportions of PWID who obtained syringes from pharmacies by city while controlling for sociodemographics, injection practices and other risk behaviors. RESULTS: Overall, most PWID were White (71%), male (63%), and between the ages of 18-25 years (55%). Compared to San Francisco, a smaller proportion of PWID in San Diego had bought syringes from pharmacies in the prior three months (16.9% vs. 49.8%; p<0.001), which remained statistically significant after adjusting for sociodemographic and behavioral factors (adjusted odds ratio=4.45, 95% confidence interval: 2.98, 6.65). CONCLUSIONS: Use of pharmacies to obtain syringes was greater where it was legal to do so. Public health policy can influence HIV and hepatitis C associated risk among PWID; however, implementation of these policies is crucial for the benefits to be realized.
Authors: M C Clatts; R Heimer; N Abdala; L A Goldsamt; J L Sotheran; K T Anderson; T M Gallo; L D Hoffer; P A Luciano; T Kyriakides Journal: J Acquir Immune Defic Syndr Date: 1999-10-01 Impact factor: 3.731
Authors: Crystal M Fuller; Jennifer Ahern; Liza Vadnai; Phillip O Coffin; Sandro Galea; Stephanie H Factor; David Vlahov Journal: J Am Pharm Assoc (Wash) Date: 2002 Nov-Dec
Authors: Lorna E Thorpe; Lawrence J Ouellet; Ronald Hershow; Susan L Bailey; Ian T Williams; John Williamson; Edgar R Monterroso; Richard S Garfein Journal: Am J Epidemiol Date: 2002-04-01 Impact factor: 4.897
Authors: Judith A Hahn; Kimberly Page-Shafer; Paula J Lum; Philippe Bourgois; Ellen Stein; Jennifer L Evans; Michael P Busch; Leslie H Tobler; Bruce Phelps; Andrew R Moss Journal: J Infect Dis Date: 2002-11-04 Impact factor: 5.226
Authors: Andy Guise; Jason Melo; Maria Luisa Mittal; Claudia Rafful; Jazmine Cuevas-Mota; Peter Davidson; Richard S Garfein; Dan Werb Journal: Int J Drug Policy Date: 2018-03-07
Authors: Tanner Nassau; Alia Al-Tayyib; William T Robinson; Jennifer Shinefeld; Kathleen A Brady Journal: Public Health Rep Date: 2020 Jul/Aug Impact factor: 2.792